Hi...
I will be starting triple tx soon with incivek. I am 1a & TT. I treated previously but did not clear until week 16 and decided to stop treatment instead of treating for 72 weeks with a low svr rate - I am hoping that the new PI may give me a better chance. I was wondering if your doctors gave you any choices with the length of your treatment time. Are you both treating for 48 weeks?
Thanks. And Good Luck ! GingerPal
Incredible good news for you! Gives those who failed treatment before lots of real hope! thanks for posting and keep posting!
Lydia
awesome news. wishing you continued success. belle
Great News!!!Its posts like these that I definatly like.Hoping continued success cindy
Great, great news!!! Keep up the awesome progress.
hereing news like that really is inspiring for your own treatment and fort everyone else.keep kicking its arse.
Your great news makes me very happy!! I am sure you are over the moon. Continued success as you conquer HCV!
Wonderful news for everyone
Congratulations and the best going forward
Great news! This is my second time treating, this time with Incevik. My viral load was over 2.5 million when I started 5 weeks ago, and they did the blood work 2 weeks in and it was 43<!!!!!! This drug is SO promising!
Congrats to you cctex
Great news!!! As someone that hasn't started the treatment journey yet, you give me hope!!! Thanks for sharing!!
Vann
Thank you! Big *sigh!*
Liz
Third time treating.
Well I think you earned not having any sides. Sounds very positive this time. Good luck on the SVR this time and god bless.
Bob.
Chica - You've positively made my day! I'm incredibly happy for you. I know you have your down times and join the wah wah sisterhood. But, you're fighting the fight. And I'll be darned if you're not winning!!!! Good for you! XOXOXOXO Karen :)
Teleprevir (Incivek) Pegasys & Ribavirin. Geno1. Stage4a. Third time treating.
:) Thanks!!!
Wonderful news! Are you on triple therapy? If so, Boceprevir (Victrelis) or Teleprevir (Incivek). That is great two about no overwhelming sides.